we aim to make cybersecurity as easy as possible for clinicians and patients, so that patients can be assured their personal information is safe
Arab Health, Dubai International Convention & Exhibition Centre,
30 January – 2 February 2017
Dubai, UAE — Imprivata®, the healthcare IT security company, will be demonstrating its latest solutions for authentication, access management, and patient identification at Arab Health. New to the MENA region, Imprivata PatientSecure®, a patient identity solution that uses palm vein biometrics, will be on show together with Imprivata OneSign®, the single sign-on (SSO) and access management platform, and Imprivata Confirm ID®, a solution for authentication of clinical transactions and medical devices. Sidra Medical and Research Center has an enterprise licence for Imprivata PatientSecure which is integrated with the Cerner Millennium workflow and used at its outpatient clinics, and will be rolled out across the organization as more services and facilities are opened.
Imprivata PatientSecure stops patient misidentification errors at the source and prevents the creation of duplicate medical records, providing a safer, streamlined and more modern patient experience. It creates a direct match between individual patients and their unique medical records across disparate clinical systems using palm vein biometric information. Once identified using Imprivata PatientSecure, the patient’s medical records are accessible to the care team immediately, ensuring that the best possible care can be delivered. Accurate identification reduces check-in time and can improve cash flow for hospitals and clinics by reducing denied insurance claims and confirming that the person presenting for treatment is entitled to that treatment.
Imprivata OneSign is the leading healthcare enterprise single sign-on and virtual desktop access platform. Imprivata OneSign gives clinicians No Click Access® to clinical administrative applications by replacing passwords with a single badge tap or swipe of a fingerprint. This saves time for the clinician, when measured, up to 45 minutes per shift, allowing them to focus more on patient care and less on technology.
Imprivata Confirm ID delivers a complete strong authentication platform for the healthcare enterprise. Imprivata Confirm ID is a single, centralised solution that enables users to transact with patient health information securely and conveniently across EHRs, clinical applications, and medical devices.
Carina Edwards, Senior Vice President Customer Experience at Imprivata commented; “Arab Health has the reputation for being the largest exhibition for healthcare professionals in the Middle East and North Africa region, an area that is strategically important to Imprivata. We see Arab Health as a key investment for Imprivata that demonstrates our commitment to the local market.
“At Imprivata we aim to make cybersecurity as easy as possible for clinicians and patients, so that patients can be assured their personal information is safe at all times. We are delighted to be working with Sidra Medical and Research Center, our first signing for Imprivata PatientSecure in the region, and the first of many.”
By providing a comprehensive platform for single sign-on, authentication management, and positive patient identification, Imprivata is able to enhance and streamline clinical workflows, making access to patient information seamless, accurate, and much quicker.
To learn more about Imprivata solutions visit; IMPRIVATA
NOTES TO EDITORS
Imprivata®, the healthcare IT security company, enables healthcare globally to access, communicate, and transact patient information securely and conveniently. The Imprivata platform addresses critical compliance and security challenges while improving productivity and the patient experience.
For more information please visit: www.imprivata.co.uk
Andreina West/Mary Phillips
+44 (0) 1491 845553
This press release was distributed by ResponseSource Press Release Wire on behalf of PR Artistry in the following categories: Computing & Telecoms, for more information visit https://pressreleasewire.responsesource.com/about.